English中文

Offstream
news



Changes

  1. The Therapeutic Goods Administration approves the usage of the Pfizer-BioNTech COVID-19 vaccine as booster dose for people aged above 18, which can be administered at least six months after received their second dose.
  2. The Therapeutic Goods Administration approves the usage of the Pfizer-BioNTech COVID-19 vaccine as a booster dose for people over the age of 18 years old, which can be administered at least six months after the second dose.

Related